Zeitelhofer, M., Adzemovic, M. Z., Moessinger, C., Stefanitsch, C., Strell, C., Muhl, L., . . . Nilsson, I. (2020). Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier. Nature Portfolio.
Cita Chicago Style (17a ed.)Zeitelhofer, Manuel, et al. Blocking PDGF-CC Signaling Ameliorates Multiple Sclerosis-like Neuroinflammation by Inhibiting Disruption of the Blood–brain Barrier. Nature Portfolio, 2020.
Cita MLA (8a ed.)Zeitelhofer, Manuel, et al. Blocking PDGF-CC Signaling Ameliorates Multiple Sclerosis-like Neuroinflammation by Inhibiting Disruption of the Blood–brain Barrier. Nature Portfolio, 2020.
Precaución: Estas citas no son 100% exactas.